A consecutive series of 78 patients having percutaneous transluminal coronary angioplasty for single vesselcorpnary artery disease and 85 patients having single vessel coronary artery bypass graft surgery were followed up prospectively for 1 year. Days in hospital and angiographic and revascularization procedures were counted in the two groups of patients and total cost of care for 12 months was calculated using current billing levels.
Since its introduction in 1977 (1,2), percutaneous transluminal coronary angioplasty has become an established alternative to coronary artery bypass graft surgery for selected patients with coronary occlusive disease. Advantages of angioplasty over bypass surgery include avoidance of thoracotomy, more prompt recovery and potentially lower cost. Disadvantages are that patients with initially unsuccessful angioplasty or with late restenosis (3) (4) (5) have more procedures, extra time in the hospital and increased cost. Although others (6, 7) have estimated the economic effect of initial angioplasty failure and late restenosis, no study has documented it. The present study compares the actual cost of coronary angioplasty and bypass surgery in a consecutive series of patients followed up prospectively from the initial procedure through the subsequent 12 months.
Methods
Patients. A consecutive series of 1,064 patients referred for myocardial revascularization form the basis of this study. Of these, 293 patients had bypass surgery during the IO © 1985 by the American College of Cardiology Angioplasty was initially successful in 74% of patients; because of initial failure in 26% and late restenosis in 18%, bypass surgery was ultimately needed in 23 of 78 patients having coronary angioplasty. Nevertheless, total cost of care per patient was 43% lower for those having angioplasty as an initial procedure for single vesselcoronary artery disease.
(J Am Coli CardioI1985; 5:16-20) months before the introduction of angioplasty in our hospital; 51 of these patients had single vessel bypass surgery (Group I, Table I ). The remaining 771 patients had a revascularization procedure during the subsequent 24 months; of these, 34 had single vessel bypass surgery (Group Ill, 58 had single vessel angioplasty that was initially successful (Group III) and 20 had an unsuccessful angioplasty attempt (Group IV). These patients with a single vessel revascularization procedure (Groups I to IV) were followed up prospectively for 12 months both by direct contact and review of hospital records. One patient having angioplasty (Group III) and three having bypass surgery (Groups I and II) were lost to follow-up; thus, 12 month follow-up data were available for 98% of patients (159 of 163).
Procedures. The indications for revascularization in the 163 patients with single vessel disease were recent onset or unstable angina, angina not adequately controlled by medical therapy or acute myocardial infarction successfully treated with intracoronary streptokinase (8) . A coronary lesion appropriate for angioplasty was defined as proximal, discrete and subtotal. Angioplasty was performed using the protocol and catheter system described by Gruentzig et al. (2) . This initial series of patients was treated with a dilating catheter having a 5 mm fixed guide wire at its tip (2), and no patient was treated with more recently introduced steerable guide wire systems (9) . All procedures were performed using the femoral approach. Successful angioplasty was defined as a 0735-1097/85/$3.30 20% or greater reduction in mean stenosis as measured from pre-and post-dilation angiograms using two oblique views whenever possible (2) . Drug therapy before and after angioplasty was similar to that reported by Gruentzig et ai. (2) . Patients were routinely monitored with radiotelemetry after angioplasty, but not in the intensive care unit unless chest pain was present. Patients having angioplasty were usually discharged 2 days after the procedure.
Coronary bypass surgery was performed using standard techniques. The left internal mammary artery was preferentially used to graft the left anterior descending coronary artery. Follow-up coronary angiography was routinely advised for patients having successful angioplasty, but not for patients having bypass surgery.
Statistics. Statistical comparison of categorical data was performed using the chi-square test, and for continuous variables using Student's t test for unpaired variables.
Results
Indications for revascularization. There appeared to be no change in the indication for surgical revascularization for single vessel coronary artery disease after introduction of angioplasty. Single vessel bypass surgery was performed in 51 (18%) of 293 patients in the 10 months before the angioplasty program was begun, and a single vessel revascularization procedure was performed in 112 (15%) of 771 patients over the subsequent 24 months. During this time. angioplasty was performed in 78 (10%) of 771 patients.
Clinical characteristics. Age and sex distribution were simliar in the different study groups (Table I) . Distribution of coronary artery disease also was similar, with a majority of the patients having left anterior descending coronary artery disease. The exception was Group II patients who were judged technically unsuitable for angioplasty and who had a higher proportion of left circumflex or right coronary artery disease.
Outcome. Angioplasty was initially successful in 58 (74%) of 78 patients. The success rate was similar for those with left anterior descending and right coronary artery stenoses (Table I) . Of 20 patients having unsuccessful angioplasty, 18 went directly from the catheterization laboratory to the operating room for bypass surgery. Eight were having chest pain at the time of surgery, but only five of these had ST-T wave changes on the electrocardiogram. Twenty patients having angioplasty (Groups III and IV) and four having bypass surgery (all in Group II) had revascularization procedures within 5 days of intracoronary streptokinase therapy for acute myocardial infarction. Angioplasty was initially successful in 15 (75%) of these 20 patients after infarction.
Operative mortality was low. One patient (Group II) died as a result of cardiogenic shock after bypass surgery; this patient had been treated with intracoronary streptokinase for acute anterior myocardial infarction 2 days before bypass surgery.
One death could be attributed to angioplasty . This was a 44 year old man with acute anterior infarction who had recanalization of an occluded left anterior descending coronary artery after intracoronary streptokinase therapy. Because of tight stenosis of the proximal segment of the artery, immediate angioplasty was attempted. The artery was dissected and reoccluded; the patient developed intractable ventricular fibrillation and died. One other patient who had lysis of an anterior descending artery thrombus with intracoronary streptokinase remained in cardiogenic shock for 3 days after infarction; angioplasty was performed successfully, but he died from persistent cardiogenic shock 36 hours later. There was no evidence of recurrent ischemia.
To summarize. there were no early deaths from either angioplasty or bypass surgery in patients with angina pectoris. All three early deaths occurred in patients who had been treated recently with intracoronary streptokinase for acute myocardial infarction.
Length of hospitalization and return to work. The length of hospitalization was significantly shorter for Group III (successful angioplasty) than for any other treatment group (Table 2) . Group IV patients with unsuccessful angioplasty, 18 of whom had immediate bypass surgery, had a longer average hospital stay than either group having bypass surgery alone ( Table 2 ). The excessive mean hospital stay in Group IV patients occurred as a result of a single Early recovery was common for patients having successf ul angioplasty ; 57 % (33 of 58) reported that their exerci se capability had reached or surpassed that at baseline by 3 weeks after angioplasty (Table 2 ). In contrast, only rarely did any patien t having bypass surgery report a return of exercise status to normal within 3 weeks of surgery . Most patients in all treatment groups who were employed before reva scularization surgery returned to work. Our general recommendation for patients havi ng succe ssful angioplasty was return to work I week after angioplasty, and 16 (42%) did ; 58 % had returned to work within I month after angioplasty. Only rarely did patients having bypa ss surgery return to work within I mon th after surgery .
Long-term follo w-up. Most patients in all treatment groups did well during the 12 mon ths after revasc ularization (Tab le 3) . There was one late death after bypass surgery (Groups] and II) in a patient who had myocardial infarction , One patient in Gro up III (successful angioplasty) died suddenly while doing unusually heavy work in a snowstorm 6 month s after angioplasty. Angiography 2 months before had shown no evidence of restenosis . This patient had complained of exertional chest discomfort the week before he died , but did not seek medical attention . Table 3 ). Angina pectoris also was rare among patients having bypass surgery, and recurrence of angina in eight patients afte r angioplasty (Group III) reflected restenosis in all cases. The average number of days in the hospital during the 12 months after the index hospitalization was higher for patients having angioplasty , but this included routine admission for followup catheterization in 30 asymptomatic patients. When the routine catheterization and noncardiac admissions were excluded, total time in the hospital for Group III patients still was higher as a result of late resteno sis in 10 of the 58 patient s. Examination of Group III patient s with and without late restenosis shows that the former had more hospital admi ssion s. more time in the hospital and more procedures (Table 4) .
Myocardial infarction was infrequent (
Comparative costs. Although angioplasty is less expensive than bypass surgery , primary failure of angioplasty and late restenosis result in more procedures and more time in the hospital (Tables 2 to 4) which increase the cost of care . To evalu ate overall cost of angioplasty relative to bypass surgery, patients who had bypass surgery as a primary procedure (Groups I and II) were compared with those who had angioplasty (Groups III and IV) ( Table 5 ). The total time in the hospital including postoperative recovery and hosp italization during the subsequent 12 month s was similar for the two groups, but the data include the patient described earlier who was in the hospital for 150 day s after angioplasty . Excluding this patient, patients who had an- (Table 5) .
Patient charges for each item (days in hospital. angiogram, angioplasty and bypass surgery) have been multiplied by their frequency. providing an index of total cost of care (Table 5) . Charges for bypass surgery and angioplasty include physician fees. Not included in this analysis are laboratory charges and cost of outpatient care. The major savings are a result of the much lower cost of angioplasty compared with bypass surgery. When comparing bypass surgery with angioplasty as the initial revascularization procedure (Table 5) , the total cost of the procedure plus care over the next 12 months was 43% lower for the average patient having angioplasty ($7,689 versus $13,559).
Discussion
Clinical course after coronary angioplasty versus bypass surgery. The impact of coronary angioplasty can be viewed in two basic ways. The first is clinical. In our series, 48 (62%) of 78 patients had their symptomatic coronary artery disease successfully treated by angioplasty. This group of patients had prompt recovery after the procedure and a shorter hospitalization. Return of exercise capability was swift, and a majority returned to work within I month. These results underscore the lower morbidity associated with angioplasty as compared with bypass surgery. When angioplasty was not initially successful. most patients underwent bypass surgery (Group IV). These patients had more days in the hospital postoperatively than did patients having bypass surgery as the initial procedure, but this result was skewed by one patient (described earlier) who spent 150 days in hospital. In all other respects. the experience of patients having surgery after unsuccessful angioplasty was similar to that of others having bypass surgery. Patients with initially successful angioplasty and late restenosis had prompt recovery after angioplasty. but restenosis resulted in extra time in hospital over the next 6 months and multiple procedures. Although emotional factors were not addressed specifically by this study, these patients also had additional anxiety and uncertainty as a result of restenosis. Effect on cost of care. A second and important impact of angioplasty is its effect on cost of care. Our results indicate a 43% savings when angioplasty is employed as the initial procedure for the patient with single vessel coronary artery disease requiring revascularization. Late restenosis caused more hospital admissions and procedures for the angioplasty group, thereby increasing overall cost. However, this was far outweighed by the lower cost of angieplasty when compared with bypass surgery (Table 5) .
Comparison with previous trials. A difference between the present study and a multicenter trial of angioplasty (6,7) is that our clinical follow-up of both angioplasty and bypass surgery patients was actual rather than estimated. Days in hospital and procedures were counted, and the economic effects of late complications such as failure of bypass surgery or restenosis after angioplasty were documented. In the National Cooperative Study (6) of angioplasty, the number of days in the hospital after either angioplasty or bypass surgery was similar to that of the present study. That study also identified restenosis and initial failure of angioplasty as causes of increased cost (7) , but did not quantitate extra time in hospital and procedures resulting from early or late angioplasty failure.
Surgical failure rate. When comparing angioplasty with bypass surgery, the National Cooperative Study (6,7) estimated a 10 to 20% failure rate of bypass surgery. Our data suggest that this estimate is excessive when considering cost. Bypass graft occlusion rates may be lower for arteries judged suitable for angioplasty. Although the rate of graft occlusion was not assessed angiographically in our study, coronary events after bypass surgery were uncommon, repeat angiography was needed infrequently and only one patient required a second operation. The stable clinical course of patients during the year after single vessel bypass surgery observed in this study suggests either the bypass graft occlusion rate is low or that graft occlusion cannot be equated with clinical failure.
Return to work. Most patients having both angioplasty and bypass surgery returned to work, which was a result similar to that reported by Holmes et a1. (10) . This unusually high rate of return to work when compared with other studies of bypass surgery (11) (12) (13) (14) may reflect less extensive coronary artery disease and the relative youth of our patients. We and others have shown that patients return to work much sooner after angioplasty than after bypass surgery, resulting in a greater savings in wages and productivity. These data were not included in our analysis of savings but further weight cost consideration in favor of angioplasty.
Future developments. Further development of the technique of angioplasty may be expected to improve its effectiveness and therefore, savings. Our primary success rate of 74% for coronary angioplasty is similar to that at other centers with new angioplasty programs (2, 15) . Increased primary success rates with increased operator experience or new guide wire catheter systems (9) will further increase savings from angioplasty. In addition, changes in angioplasty technique may lower the rate of late restenosis ( I&-18), which was the single most important contributor to increased cost of angioplasty. Additional savings may result from substitution of noninvasive outpatient evaluation of late patency for routine follow-up angiography (/9). Even with the inherent problems of a new technique and the dilemma of late restenosis, our results demonstrate a substantial savings when angioplasty was used instead of bypass surgery as the initial revascularization technique for patients with single vessel coronary artery disease.
